We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ADBE:NASDAQAdobe Inc. Analysis

Data as of 2026-03-09 - not real-time

$282.44

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Adobe Inc. (ADBE) presents a compelling valuation case – its discounted cash‑flow estimate suggests a sizable upside, while fundamentals such as high gross and operating margins, robust free cash flow, and an exceptionally strong return on equity underscore durable profitability. The company carries a modest debt load relative to cash, and although it does not pay a dividend, the balance sheet is solid and the forward earnings multiple is well below the industry average, indicating a growth‑value blend that is currently undervalued.
On the technical side, the stock is trading below its short‑ and long‑term moving averages, reflecting a bearish price trend and a recent decline in volume. Nonetheless, the MACD histogram is positive and the RSI sits in a neutral zone, hinting at potential short‑term momentum recovery. Upcoming earnings and heightened scrutiny over AI competition are key catalysts that could swing sentiment, making the current support level a focal point for risk‑reward considerations.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish bias
  • Positive MACD histogram suggesting emerging momentum
  • Upcoming earnings release as a near‑term catalyst

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued DCF fair value with substantial upside potential
  • Strong profitability metrics and cash generation
  • Strategic AI initiatives that could expand addressable market

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained high margins and return on equity
  • Robust balance sheet with ample liquidity
  • Long‑term secular demand for digital media and experience software

Key Metrics & Analysis

Financial Health

Revenue Growth10.50%
Profit Margin30.00%
P/E Ratio16.9
ROE55.43%
ROA18.22%
Debt/Equity57.27
P/B Ratio10.0
Op. Cash Flow$10.0B
Free Cash Flow$8.8B
Industry P/E36.8

Technical Analysis

TrendBearish
RSI56.2
Support$244.28
Resistance$285.36
MA 20$264.53
MA 50$293.24
MA 200$342.37
MACDBullish
VolumeDecreasing
Fear & Greed Index75.89

Valuation

Fair Value$453.81
Target Price$387.50
Upside/Downside37.20%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.84
Volatility39.03%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.